Migraine Disorders
|
0.330 |
GeneticVariation
|
group |
BEFREE |
We investigated the possible association of the most common single nucleotide polymorphisms (SNPs) in the GABA receptor alpha4 (GABRA4), epsilon (GABRE), and theta (GABRQ) genes with the risk for migraine.
|
29299688 |
2018 |
Migraine Disorders
|
0.330 |
Biomarker
|
group |
GENOMICS_ENGLAND |
Targeted Next-Generation Sequencing Analysis of 1,000 Individuals with Intellectual Disability.
|
26350204 |
2015 |
Migraine Disorders
|
0.330 |
GeneticVariation
|
group |
BEFREE |
The AT genotype of rs3810651 of GABRQ gene was associated with an increased risk for migraine (OR: 4.07; 95% CI: 1.71-9.73, p=0.002), while the CT genotype of rs3902802 (OR: 0.41; 95% CI: 0.21-0.78, p=0.006) and GA genotype of rs2131190 of GABRA3 gene (OR: 0.53; 95% CI: 0.32-0.88, p=0.013) seem to be protective factors.
|
24040174 |
2013 |
Migraine Disorders
|
0.330 |
Biomarker
|
group |
BEFREE |
In this study, we have focused on the subunit GABA A receptors type epsilon (GABRE) and type theta (GABRQ) genes and their involvement in migraine.
|
19087248 |
2008 |
Schizophrenia
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
Schizophrenia-related deficits in theta generation are also observed not only in MMN, but also in other auditory and visual contexts.
|
28666633 |
2018 |
Schizophrenia
|
0.310 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Targeted Next-Generation Sequencing Analysis of 1,000 Individuals with Intellectual Disability.
|
26350204 |
2015 |
Atrial Septal Defects
|
0.300 |
Biomarker
|
group |
GENOMICS_ENGLAND |
Targeted Next-Generation Sequencing Analysis of 1,000 Individuals with Intellectual Disability.
|
26350204 |
2015 |
Autism Spectrum Disorders
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Targeted Next-Generation Sequencing Analysis of 1,000 Individuals with Intellectual Disability.
|
26350204 |
2015 |
ATRIAL SEPTAL DEFECT 1
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Targeted Next-Generation Sequencing Analysis of 1,000 Individuals with Intellectual Disability.
|
26350204 |
2015 |
Liver carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
A recent study reported that GABRQ is involved in the initiation and progression of hepatocellular carcinoma; however, the role of GABRQ in ccRCC remains unknown.
|
31788046 |
2019 |
Asthma
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Glutathione- S-transferase micro and theta gene polymorphisms as new risk factors of atopic bronchial asthma.
|
11862323 |
2002 |
Asthma
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Polymorphisms of N-acetyltransferase 2, glutathione S-transferase mu and theta genes as risk factors of bladder cancer in relation to asthma and tuberculosis.
|
10840461 |
2000 |
Liver carcinoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Both zeta and theta gene expression appears erythroid specific in that neither mRNA species is detected in RNA isolated from brain tissue, peripheral blood mononuclear cells, or three nonerythroid cell lines (B-lymphocyte, T-lymphocyte, and hepatoma cell lines).
|
2752137 |
1989 |
Anxiety
|
0.010 |
Biomarker
|
disease |
BEFREE |
Anxiety process "theta" biomarker in the stop signal task eliminated by a preceding relaxation test.
|
31219261 |
2019 |
Anxiety Disorders
|
0.010 |
Biomarker
|
group |
BEFREE |
Anxiety process "theta" biomarker in the stop signal task eliminated by a preceding relaxation test.
|
31219261 |
2019 |
Conventional (Clear Cell) Renal Cell Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
A recent study reported that GABRQ is involved in the initiation and progression of hepatocellular carcinoma; however, the role of GABRQ in ccRCC remains unknown.
|
31788046 |
2019 |
Breast Carcinoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Role of the renin-angiotensin-aldosterone system and the glutathione S-transferase Mu, Pi and Theta gene polymorphisms in cardiotoxicity after anthracycline chemotherapy for breast carcinoma.
|
23999848 |
2013 |
Tremor
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
The GABRQ-478F allele seemed to be related to improvement of tremor with ethanol use among men (odds ratio=2.32, 95% confidence interval=0.26-4.3, P=0.007, Pc=0.021).
|
21422964 |
2011 |
Essential Tremor
|
0.010 |
Biomarker
|
disease |
BEFREE |
The results of this study suggest that the single nucleotide polymorphisms studied in the GABRA4, GABRE, and GABRQ genes are not related to the risk for familial ET.
|
21422964 |
2011 |
Malignant neoplasm of urinary bladder
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Polymorphisms of N-acetyltransferase 2, glutathione S-transferase mu and theta genes as risk factors of bladder cancer in relation to asthma and tuberculosis.
|
10840461 |
2000 |
Bladder Neoplasm
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Polymorphisms of N-acetyltransferase 2, glutathione S-transferase mu and theta genes as risk factors of bladder cancer in relation to asthma and tuberculosis.
|
10840461 |
2000 |
Tuberculosis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Polymorphisms of N-acetyltransferase 2, glutathione S-transferase mu and theta genes as risk factors of bladder cancer in relation to asthma and tuberculosis.
|
10840461 |
2000 |
Carcinoma of bladder
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Polymorphisms of N-acetyltransferase 2, glutathione S-transferase mu and theta genes as risk factors of bladder cancer in relation to asthma and tuberculosis.
|
10840461 |
2000 |
Malignant neoplasm of lung
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Polymorphisms in the glutathione S-transferase class mu and theta genes interact and increase susceptibility to lung cancer in minority populations (Texas, United States).
|
9242470 |
1997 |
Carcinoma of lung
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Polymorphisms in the glutathione S-transferase class mu and theta genes interact and increase susceptibility to lung cancer in minority populations (Texas, United States).
|
9242470 |
1997 |